Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19
Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid autoantibodies in sera samples from 120 adult hospitalized patients with COVID-19 in comparison to pre-pandemic samples from 100 healthy...
Saved in:
| Published in | Journal of translational autoimmunity (Online) Vol. 4; p. 100091 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.01.2021
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid autoantibodies in sera samples from 120 adult hospitalized patients with COVID-19 in comparison to pre-pandemic samples from 100 healthy individuals. In addition, to estimate the frequency of these autoantibodies in COVID-19, a meta-analysis of selected articles was conducted. Hospitalized patients with COVID-19 had latent autoimmunity characterized by a high frequency of anti-thyroid peroxidase antibodies, rheumatoid factor (RF), anti-cyclic citrullinated peptide third generation antibodies, antinuclear antibodies (ANAs), IgM anti-β2-glycoprotein I (β2GP1) and IgM anti-cardiolipin antibodies. The meta-analysis confirmed our results, with RF and ANAs being the most common autoantibodies. In addition, cluster analysis revealed that those patients with high frequency of RF, IgM anti-β2GP1 antibodies and ANAs had a longer hospital stay, required more vasopressors during hospitalization, and were more likely to develop critical disease. These data suggest that latent autoimmunity influences the severity of COVID-19, and support further post-COVID studies in order to evaluate the development of overt autoimmunity.
•Hospitalized patients with COVID-19 exhibit latent rheumatic, thyroid and antiphospholipid autoimmunity.•ANAs, RF, CCP3, antiphospholipid and anti-TPO antibodies are the most common autoantibodies in patients with COVID-19.•Levels of IgG ACA are associated with critical illness.•The presence of ANAs, RF, and IgM anti-β2GP1 antibodies is a risk factor for critical disease. |
|---|---|
| AbstractList | Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid autoantibodies in sera samples from 120 adult hospitalized patients with COVID-19 in comparison to pre-pandemic samples from 100 healthy individuals. In addition, to estimate the frequency of these autoantibodies in COVID-19, a meta-analysis of selected articles was conducted. Hospitalized patients with COVID-19 had latent autoimmunity characterized by a high frequency of anti-thyroid peroxidase antibodies, rheumatoid factor (RF), anti-cyclic citrullinated peptide third generation antibodies, antinuclear antibodies (ANAs), IgM anti-β2-glycoprotein I (β2GP1) and IgM anti-cardiolipin antibodies. The meta-analysis confirmed our results, with RF and ANAs being the most common autoantibodies. In addition, cluster analysis revealed that those patients with high frequency of RF, IgM anti-β2GP1 antibodies and ANAs had a longer hospital stay, required more vasopressors during hospitalization, and were more likely to develop critical disease. These data suggest that latent autoimmunity influences the severity of COVID-19, and support further post-COVID studies in order to evaluate the development of overt autoimmunity.
•
Hospitalized patients with COVID-19 exhibit latent rheumatic, thyroid and antiphospholipid autoimmunity.
•
ANAs, RF, CCP3, antiphospholipid and anti-TPO antibodies are the most common autoantibodies in patients with COVID-19.
•
Levels of IgG ACA are associated with critical illness.
•
The presence of ANAs, RF, and IgM anti-β2GP1 antibodies is a risk factor for critical disease. Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid autoantibodies in sera samples from 120 adult hospitalized patients with COVID-19 in comparison to pre-pandemic samples from 100 healthy individuals. In addition, to estimate the frequency of these autoantibodies in COVID-19, a meta-analysis of selected articles was conducted. Hospitalized patients with COVID-19 had latent autoimmunity characterized by a high frequency of anti-thyroid peroxidase antibodies, rheumatoid factor (RF), anti-cyclic citrullinated peptide third generation antibodies, antinuclear antibodies (ANAs), IgM anti-β2-glycoprotein I (β2GP1) and IgM anti-cardiolipin antibodies. The meta-analysis confirmed our results, with RF and ANAs being the most common autoantibodies. In addition, cluster analysis revealed that those patients with high frequency of RF, IgM anti-β2GP1 antibodies and ANAs had a longer hospital stay, required more vasopressors during hospitalization, and were more likely to develop critical disease. These data suggest that latent autoimmunity influences the severity of COVID-19, and support further post-COVID studies in order to evaluate the development of overt autoimmunity. Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid autoantibodies in sera samples from 120 adult hospitalized patients with COVID-19 in comparison to pre-pandemic samples from 100 healthy individuals. In addition, to estimate the frequency of these autoantibodies in COVID-19, a meta-analysis of selected articles was conducted. Hospitalized patients with COVID-19 had latent autoimmunity characterized by a high frequency of anti-thyroid peroxidase antibodies, rheumatoid factor (RF), anti-cyclic citrullinated peptide third generation antibodies, antinuclear antibodies (ANAs), IgM anti-β2-glycoprotein I (β2GP1) and IgM anti-cardiolipin antibodies. The meta-analysis confirmed our results, with RF and ANAs being the most common autoantibodies. In addition, cluster analysis revealed that those patients with high frequency of RF, IgM anti-β2GP1 antibodies and ANAs had a longer hospital stay, required more vasopressors during hospitalization, and were more likely to develop critical disease. These data suggest that latent autoimmunity influences the severity of COVID-19, and support further post-COVID studies in order to evaluate the development of overt autoimmunity.Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid autoantibodies in sera samples from 120 adult hospitalized patients with COVID-19 in comparison to pre-pandemic samples from 100 healthy individuals. In addition, to estimate the frequency of these autoantibodies in COVID-19, a meta-analysis of selected articles was conducted. Hospitalized patients with COVID-19 had latent autoimmunity characterized by a high frequency of anti-thyroid peroxidase antibodies, rheumatoid factor (RF), anti-cyclic citrullinated peptide third generation antibodies, antinuclear antibodies (ANAs), IgM anti-β2-glycoprotein I (β2GP1) and IgM anti-cardiolipin antibodies. The meta-analysis confirmed our results, with RF and ANAs being the most common autoantibodies. In addition, cluster analysis revealed that those patients with high frequency of RF, IgM anti-β2GP1 antibodies and ANAs had a longer hospital stay, required more vasopressors during hospitalization, and were more likely to develop critical disease. These data suggest that latent autoimmunity influences the severity of COVID-19, and support further post-COVID studies in order to evaluate the development of overt autoimmunity. Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid autoantibodies in sera samples from 120 adult hospitalized patients with COVID-19 in comparison to pre-pandemic samples from 100 healthy individuals. In addition, to estimate the frequency of these autoantibodies in COVID-19, a meta-analysis of selected articles was conducted. Hospitalized patients with COVID-19 had latent autoimmunity characterized by a high frequency of anti-thyroid peroxidase antibodies, rheumatoid factor (RF), anti-cyclic citrullinated peptide third generation antibodies, antinuclear antibodies (ANAs), IgM anti-β2-glycoprotein I (β2GP1) and IgM anti-cardiolipin antibodies. The meta-analysis confirmed our results, with RF and ANAs being the most common autoantibodies. In addition, cluster analysis revealed that those patients with high frequency of RF, IgM anti-β2GP1 antibodies and ANAs had a longer hospital stay, required more vasopressors during hospitalization, and were more likely to develop critical disease. These data suggest that latent autoimmunity influences the severity of COVID-19, and support further post-COVID studies in order to evaluate the development of overt autoimmunity. •Hospitalized patients with COVID-19 exhibit latent rheumatic, thyroid and antiphospholipid autoimmunity.•ANAs, RF, CCP3, antiphospholipid and anti-TPO antibodies are the most common autoantibodies in patients with COVID-19.•Levels of IgG ACA are associated with critical illness.•The presence of ANAs, RF, and IgM anti-β2GP1 antibodies is a risk factor for critical disease. |
| ArticleNumber | 100091 |
| Author | Montoya-García, Norma Ramírez-Santana, Carolina Acosta-Ampudia, Yeny Mancera-Navarro, Laura Milena Monsalve, Diana M. Rojas, Manuel Rodríguez-Leguizamón, Giovanni Rodríguez, Yhojan Anaya, Juan-Manuel Villadiego-Santana, Ana María |
| Author_xml | – sequence: 1 givenname: Juan-Manuel surname: Anaya fullname: Anaya, Juan-Manuel email: juan.anaya@urosario.edu.co organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 2 givenname: Diana M. surname: Monsalve fullname: Monsalve, Diana M. organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 3 givenname: Manuel surname: Rojas fullname: Rojas, Manuel organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 4 givenname: Yhojan surname: Rodríguez fullname: Rodríguez, Yhojan organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 5 givenname: Norma surname: Montoya-García fullname: Montoya-García, Norma organization: Clínica del Occidente, Bogota, Colombia – sequence: 6 givenname: Laura Milena surname: Mancera-Navarro fullname: Mancera-Navarro, Laura Milena organization: Clínica del Occidente, Bogota, Colombia – sequence: 7 givenname: Ana María surname: Villadiego-Santana fullname: Villadiego-Santana, Ana María organization: Clínica del Occidente, Bogota, Colombia – sequence: 8 givenname: Giovanni surname: Rodríguez-Leguizamón fullname: Rodríguez-Leguizamón, Giovanni organization: Hospital Universitario Mayor – Méderi, Universidad del Rosario, Bogota, Colombia – sequence: 9 givenname: Yeny surname: Acosta-Ampudia fullname: Acosta-Ampudia, Yeny organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 10 givenname: Carolina surname: Ramírez-Santana fullname: Ramírez-Santana, Carolina organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33681751$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUk1v1DAQtVARLaX_AKEcOZDF43wOB6RqKbDSSr0ARyzHdhqvknixnaLl19chS9VygINla-a9NzOe95ycjHbUhLwEugIK5dvdahfEFOyKUQYxRCnCE3LGihpTpEhPHrxPyYX3uwhhBQCU7Bk5zbKyhqqAM_J9K4IeQ-I6PQ0iGPkmCd3BWaMSMapk31kfT2_2cyAWNMMwjSYcEjMmc84E0ZtfOiIjOQr55KcJXbK-_rb5kAK-IE9b0Xt9cbzPydePV1_Wn9Pt9afN-nKbyoJhSNu2VAKVrBTLdSbLitU1ImMCcipRMIF1U7QiQwDFMC8KyIu6VU3JEFoBTXZONouusmLH984Mwh24FYb_Dlh3w4WL0_WaI6W1LjNaI5M5CGwy0IWqcoEQO5Ayar1ftPZTM2gl41RO9I9EH2dG0_Ebe8srZLRmeRR4fRRw9sekfeCD8VL3vRi1nTxnOcbpSqRVhL56WOu-yJ8FRUC-AKSz3jvd3kOA8tkKfMcXK_DZCnyxQqS9-4sm46aCsXPHpv8f-fgBOm7s1mjHvYy7lVoZp2WIX2r-LXAHw2vSMA |
| CitedBy_id | crossref_primary_10_1016_j_jtauto_2023_100204 crossref_primary_10_3390_biomedicines13020516 crossref_primary_10_1007_s00108_022_01368_y crossref_primary_10_1016_j_beha_2022_101402 crossref_primary_10_1016_j_dsx_2024_103087 crossref_primary_10_1093_infdis_jiac017 crossref_primary_10_1002_dmrr_3824 crossref_primary_10_1007_s11926_021_01029_3 crossref_primary_10_1038_s41467_024_53356_5 crossref_primary_10_1016_j_tmaid_2022_102314 crossref_primary_10_1007_s42977_023_00153_8 crossref_primary_10_1186_s12879_022_07560_7 crossref_primary_10_3389_fimmu_2024_1354349 crossref_primary_10_3389_fendo_2024_1496155 crossref_primary_10_1111_ijcp_14867 crossref_primary_10_1016_j_acci_2024_05_001 crossref_primary_10_1016_j_autrev_2023_103409 crossref_primary_10_3389_fimmu_2024_1509289 crossref_primary_10_3390_v15051161 crossref_primary_10_1002_jmv_27292 crossref_primary_10_1080_1744666X_2022_2085561 crossref_primary_10_1002_iid3_1276 crossref_primary_10_1136_bmjopen_2023_072784 crossref_primary_10_3389_fendo_2022_938633 crossref_primary_10_1016_j_autrev_2022_103206 crossref_primary_10_3389_fendo_2023_1126683 crossref_primary_10_1111_sji_13344 crossref_primary_10_3390_v15030675 crossref_primary_10_1007_s00431_023_05097_8 crossref_primary_10_1016_j_idcr_2023_e01908 crossref_primary_10_3390_life12040517 crossref_primary_10_1016_j_jtauto_2022_100154 crossref_primary_10_3389_fimmu_2024_1314507 crossref_primary_10_1016_j_autrev_2022_103183 crossref_primary_10_1016_j_jtauto_2024_100237 crossref_primary_10_1093_infdis_jiac106 crossref_primary_10_1016_j_jaut_2023_103132 crossref_primary_10_3390_jcm12196365 crossref_primary_10_1155_2021_2395212 crossref_primary_10_1002_ccr3_5748 crossref_primary_10_1186_s12967_022_03328_4 crossref_primary_10_1016_j_jaut_2023_103070 crossref_primary_10_1080_1744666X_2021_1932467 crossref_primary_10_1007_s12325_023_02715_7 crossref_primary_10_1080_14647273_2023_2262757 crossref_primary_10_1016_j_autrev_2021_102945 crossref_primary_10_1016_j_mehy_2024_111303 crossref_primary_10_1515_cclm_2021_0511 |
| Cites_doi | 10.1093/infdis/jiaa485 10.1111/cen.12662 10.1016/j.ijid.2020.04.061 10.1136/annrheumdis-2018-214693 10.1080/10408363.2020.1770685 10.1111/cts.12805 10.1016/j.jaut.2018.11.002 10.1007/s12016-018-8709-9 10.3389/fimmu.2020.584241 10.1016/j.jaut.2020.102506 10.1016/j.jtauto.2020.100073 10.1002/art.41409 10.1016/S2213-2600(20)30404-5 10.1136/annrheumdis-2020-218009 10.1056/NEJMoa021933 10.1111/cts.12953 10.1111/cts.12908 10.1111/cen.14304 10.1016/j.ebiom.2019.03.063 10.1001/jama.2020.17023 |
| ContentType | Journal Article |
| Copyright | 2021 The Author(s) 2021 The Author(s). 2021 The Author(s) 2021 |
| Copyright_xml | – notice: 2021 The Author(s) – notice: 2021 The Author(s). – notice: 2021 The Author(s) 2021 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.jtauto.2021.100091 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2589-9090 |
| ExternalDocumentID | oai_doaj_org_article_9008e630892c41a9b31e5d74a919dccc PMC7920824 33681751 10_1016_j_jtauto_2021_100091 S2589909021000113 |
| Genre | Journal Article |
| GroupedDBID | 0SF 53G 6I. AAEDW AAFTH AALRI AAXUO ACLIJ AEXQZ AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS EJD FDB GROUPED_DOAJ M41 M~E NCXOZ OK1 ROL RPM 0R~ AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFJKZ AFPUW AIGII AKBMS AKYEP APXCP CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c529t-ff6da9dc7d24e3c672889922a140c9a2a98b5fa3911d294551458fdb6291fa1b3 |
| IEDL.DBID | DOA |
| ISSN | 2589-9090 |
| IngestDate | Wed Aug 27 01:26:24 EDT 2025 Thu Aug 21 17:13:38 EDT 2025 Fri Jul 11 06:01:16 EDT 2025 Thu Apr 03 07:03:40 EDT 2025 Tue Jul 01 03:50:17 EDT 2025 Thu Apr 24 22:53:56 EDT 2025 Tue Jul 25 21:00:10 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | COVID-19 Autoimmunity Clusters SARS-CoV-2 Latent autoimmunity |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. 2021 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c529t-ff6da9dc7d24e3c672889922a140c9a2a98b5fa3911d294551458fdb6291fa1b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Both authors contributed equally. |
| OpenAccessLink | https://doaj.org/article/9008e630892c41a9b31e5d74a919dccc |
| PMID | 33681751 |
| PQID | 2498996907 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9008e630892c41a9b31e5d74a919dccc pubmedcentral_primary_oai_pubmedcentral_nih_gov_7920824 proquest_miscellaneous_2498996907 pubmed_primary_33681751 crossref_primary_10_1016_j_jtauto_2021_100091 crossref_citationtrail_10_1016_j_jtauto_2021_100091 elsevier_sciencedirect_doi_10_1016_j_jtauto_2021_100091 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Journal of translational autoimmunity (Online) |
| PublicationTitleAlternate | J Transl Autoimmun |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Bastard, Rosen, Zhang, Michailidis, Hoffmann, Zhang, Dorgham, Philippot, Rosain, Béziat, Manry, Shaw, Haljasmägi, Peterson, Lorenzo, Bizien, Trouillet-Assant, Dobbs, de Jesus, Belot, Kallaste, Catherinot, Tandjaoui-Lambiotte, Le Pen, Kerner, Bigio, Seeleuthner, Yang, Bolze, Spaan, Delmonte, Abers, Aiuti, Casari, Lampasona, Piemonti, Ciceri, Bilguvar, Lifton, Vasse, Smadja, Migaud, Hadjadj, Terrier, Duffy, Quintana-Murci, van de Beek, Roussel, Vinh, Tangye, Haerynck, Dalmau, Martinez-Picado, Brodin, Nussenzweig, Boisson-Dupuis, Rodríguez-Gallego, Vogt, Mogensen, Oler, Gu, Burbelo, Cohen, Biondi, Bettini, D’Angio, Bonfanti, Rossignol, Mayaux, Rieux-Laucat, Husebye, Fusco, Ursini, Imberti, Sottini, Paghera, Quiros-Roldan, Rossi, Castagnoli, Montagna, Licari, Marseglia, Duval, Ghosn, Tsang, Goldbach-Mansky, Kisand, Lionakis, Puel, Zhang, Holland, Gorochov, Jouanguy, Rice, Cobat, Notarangelo, Abel, Su, Casanova (bib15) 2020; 80 Amezcua-Guerra, Rojas-Velasco, Brianza-Padilla, Vázquez-Rangel, Márquez-Velasco, Baranda-Tovar, Springall, Gonzalez-Pacheco, Juárez-Vicuña, Tavera-Alonso, Sanchez-Muñoz, Hernández-Salas (bib11) 2020 Velavan, Meyer (bib28) 2020; 95 Rodríguez, Novelli, Rojas, De Santis, Acosta-Ampudia, Monsalve, Ramírez-Santana, Costanzo, Ridgway, Ansari, Gershwin, Selmi, Anaya (bib1) 2020; 114 Wang, Mao, Klein, Dai, Huck, Liu, Zheng, Zhou, Israelow, Wong, Lucas, Silva, Oh, Song, Perotti, Fischer, Campbell, Fournier, Wyllie, Vogels, Ott, Kalinich, Petrone, Watkins, Dela Cruz, Farhadian, Schulz, Grubaugh, Ko, Iwasaki, Ring (bib18) 2020 Pascolini, Vannini, Deleonardi, Ciordinik, Sensoli, Carletti, Veronesi, Ricci, Pronesti, Mazzanti, Grondona, Silvestri, Zanuso, Mazzolini, Lalanne, Quarneti, Fusconi, Giostra, Granito, Muratori, Lenzi, Muratori (bib8) 2021 Franco, Amaya-Amaya, Molano-González, Caro-Moreno, Rodríguez-Jiménez, Acosta-Ampudia, Mantilla, Rojas-Villarraga, Anaya (bib19) 2015; 83 Arbuckle, McClain, V Rubertone, Scofield, Dennis, James, Harley (bib23) 2003; 349 Anaya, Restrepo-Jiménez, Rodríguez, Rodríguez-Jiménez, Acosta-Ampudia, Monsalve, Pacheco, Ramírez-Santana, Molano-González, Mantilla (bib26) 2019; 56 James, Chen, Young, Bemis, Seifert, Bourn, Deane, Demoruelle, Feser, O’Dell, Weisman, Keating, Gaffney, Kelly, Langefeld, Harley, Robinson, Hafler, O’Connor, Buckner, Guthridge, Norris, Holers (bib25) 2019; 42 Woodruff, Ramonell, Lee, Sanz (bib14) 2020 Gatto, Perricone, Tonello, Bistoni, Cattelan, Bursi, Cafaro, De Robertis, Mencacci, Bozza, Vianello, Iaccarino, Gerli, Doria, Bartoloni (bib9) 2020; 38 Lebart, Piron, Dunod (bib22) 1995 Sacchi, Tamiazzo, Stobbione, Agatea, De Gaspari, Stecca, Lauritano, Roveta, Tozzoli, Guaschino, Bonometti (bib7) 2021 Botello, Herrán, Salcedo, Rodríguez, Anaya, Rojas (bib21) 2020; 93 Molano-González, Rojas, Monsalve, Pacheco, Acosta-Ampudia, Rodríguez, Rodríguez-Jimenez, Ramírez-Santana, Anaya (bib24) 2019; 98 Bertin, Brodovitch, Beziane, Hug, Bouamri, Mege, Heim, Bardin (bib3) 2020; 72 Lerma, Chaudhary, Bryan, Morishima, Wener, Fink (bib6) 2020; 3 Schiaffino, Di Natale, García-Martínez, Navarro, Muñoz-Blanco, Demelo-Rodríguez, Sánchez-Mateos (bib4) 2020; 222 Casciola-Rosen, Thiemann, Andrade, Trejo Zambrano, Hooper, Leonard, Spangler, Cox, Machamer, Sauer, Laeyendecker, Garibaldi, Ray, Mecoli, Christopher-Stine, Gutierrez-Alamillo, Yang, Hines, Clarke, Rothman, Pekosz, Fenstermacher, Wang, Zeger, Rosen (bib16) 2020 (bib17) 2013 Zuniga, Gomes, Carsons, Bender, Cotzia, Miao, Lee, Rodriguez (bib32) 2021 Borghi, Beltagy, Garrafa, Curreli, Cecchini, Bodio, Grossi, Blengino, Tincani, Franceschini, Andreoli, Lazzaroni, Piantoni, Masneri, Crisafulli, Brugnoni, Muiesan, Salvetti, Parati, Torresani, Mahler, Heilbron, Pregnolato, Pengo, Tedesco, Pozzi, Meroni (bib5) 2020; 11 Ponti, Maccaferri, Ruini, Tomasi, Ozben (bib30) 2020; 57 Pacheco, Monsalve, Acosta-Ampudia, Rojas, Anaya, Ramírez-Santana (bib20) 2020; 79 Vlachoyiannopoulos, Magira, Alexopoulos, Jahaj, Theophilopoulou, Kotanidou, Tzioufas (bib10) 2020; 79 Sterne, Murthy, V Diaz, Slutsky, Villar, Angus, Annane, Azevedo, Berwanger, Cavalcanti, Dequin, Du, Emberson, Fisher, Giraudeau, Gordon, Granholm, Green, Haynes, Heming, Higgins, Horby, Jüni, Landray, Le Gouge, Leclerc, Lim, Machado, McArthur, Meziani, Møller, Perner, Petersen, Savovic, Tomazini, Veiga, Webb, Marshall (bib27) 2020; 324 Goel, Harmouch, Garg, Saraiya, Daly, Kumar, Hippen (bib31) 2020 Zuo, Estes, Ali, Gandhi, Yalavarthi, Shi, Sule, Gockman, Madison, Zuo, Yadav, Wang, Woodard, Lezak, Lugogo, Smith, Morrissey, Kanthi, Knight (bib13) 2020 Leisman, Ronner, Pinotti, Taylor, Sinha, Calfee, V Hirayama, Mastroiani, Turtle, Harhay, Legrand, Deutschman (bib29) 2020; 8 Pineton de Chambrun, Frere, Miyara, Amoura, Martin-Toutain, Mathian, Hekimian, Combes (bib12) 2020 Zhou, Han, Chen, Hou, Hua, He, Guo, Zhang, Wang, Yuan, Zhao, Zhang, Jia, Zuo, Li, Wang, Cao, Jia (bib2) 2020; 13 Casciola-Rosen (10.1016/j.jtauto.2021.100091_bib16) 2020 Rodríguez (10.1016/j.jtauto.2021.100091_bib1) 2020; 114 Pascolini (10.1016/j.jtauto.2021.100091_bib8) 2021 Franco (10.1016/j.jtauto.2021.100091_bib19) 2015; 83 Anaya (10.1016/j.jtauto.2021.100091_bib26) 2019; 56 Woodruff (10.1016/j.jtauto.2021.100091_bib14) 2020 Sacchi (10.1016/j.jtauto.2021.100091_bib7) 2021 Pacheco (10.1016/j.jtauto.2021.100091_bib20) 2020; 79 Bastard (10.1016/j.jtauto.2021.100091_bib15) 2020; 80 Zuniga (10.1016/j.jtauto.2021.100091_bib32) 2021 Botello (10.1016/j.jtauto.2021.100091_bib21) 2020; 93 Pineton de Chambrun (10.1016/j.jtauto.2021.100091_bib12) 2020 Sterne (10.1016/j.jtauto.2021.100091_bib27) 2020; 324 (10.1016/j.jtauto.2021.100091_bib17) 2013 Borghi (10.1016/j.jtauto.2021.100091_bib5) 2020; 11 Schiaffino (10.1016/j.jtauto.2021.100091_bib4) 2020; 222 Amezcua-Guerra (10.1016/j.jtauto.2021.100091_bib11) 2020 Zhou (10.1016/j.jtauto.2021.100091_bib2) 2020; 13 Arbuckle (10.1016/j.jtauto.2021.100091_bib23) 2003; 349 Gatto (10.1016/j.jtauto.2021.100091_bib9) 2020; 38 Molano-González (10.1016/j.jtauto.2021.100091_bib24) 2019; 98 Leisman (10.1016/j.jtauto.2021.100091_bib29) 2020; 8 Lerma (10.1016/j.jtauto.2021.100091_bib6) 2020; 3 Velavan (10.1016/j.jtauto.2021.100091_bib28) 2020; 95 Lebart (10.1016/j.jtauto.2021.100091_bib22) 1995 Ponti (10.1016/j.jtauto.2021.100091_bib30) 2020; 57 Goel (10.1016/j.jtauto.2021.100091_bib31) 2020 Wang (10.1016/j.jtauto.2021.100091_bib18) 2020 James (10.1016/j.jtauto.2021.100091_bib25) 2019; 42 Bertin (10.1016/j.jtauto.2021.100091_bib3) 2020; 72 Vlachoyiannopoulos (10.1016/j.jtauto.2021.100091_bib10) 2020; 79 Zuo (10.1016/j.jtauto.2021.100091_bib13) 2020 |
| References_xml | – volume: 3 start-page: 100073 year: 2020 ident: bib6 article-title: Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19) publication-title: J. Transl. Autoimmun. – volume: 38 start-page: 754 year: 2020 end-page: 759 ident: bib9 article-title: Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases publication-title: Clin. Exp. Rheumatol. – volume: 349 start-page: 1526 year: 2003 end-page: 1533 ident: bib23 article-title: Development of autoantibodies before the clinical onset of systemic lupus erythematosus publication-title: N. Engl. J. Med. – volume: 114 start-page: 102506 year: 2020 ident: bib1 article-title: Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 publication-title: J. Autoimmun. – volume: 80– start-page: 370 year: 2020 ident: bib15 article-title: Autoantibodies against type I IFNs in patients with life-threatening COVID-19 publication-title: Science – year: 2020 ident: bib31 article-title: The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities publication-title: Eur. J. Gastroenterol. Hepatol. Publish Ah – volume: 324 start-page: 1330 year: 2020 ident: bib27 article-title: Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19 publication-title: J. Am. Med. Assoc. – year: 2021 ident: bib7 article-title: SARS-CoV-2 infection as a trigger of autoimmune response publication-title: Clin. Transl. Sci. n/a – start-page: 13126 year: 2020 ident: bib12 article-title: High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? publication-title: J. Intern. Med. – volume: 11 start-page: 2692 year: 2020 ident: bib5 article-title: Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome publication-title: Front. Immunol. – year: 2020 ident: bib11 article-title: Presence of antiphospholipid antibodies in COVID-19: case series study publication-title: Ann. Rheum. Dis. – volume: 42 start-page: 76 year: 2019 end-page: 85 ident: bib25 article-title: Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients publication-title: EBioMedicine – volume: 13 start-page: 1077 year: 2020 end-page: 1086 ident: bib2 article-title: Clinical and autoimmune characteristics of severe and critical cases of COVID-19 publication-title: Clin. Transl. Sci. – year: 2021 ident: bib8 article-title: COVID-19 and immunological dysregulation: can autoantibodies be useful? publication-title: Clin. Transl. Sci. – volume: 98 year: 2019 ident: bib24 article-title: Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity publication-title: J. Autoimmun. – volume: 79 start-page: 1661 year: 2020 end-page: 1663 ident: bib10 article-title: Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 publication-title: Ann. Rheum. Dis. – start-page: 2020 year: 2021 ident: bib32 article-title: Autoimmunity to the lung protective phospholipid-binding protein annexin A2 predicts mortality among hospitalized COVID-19 patients publication-title: MedRxiv – volume: 56 start-page: 362 year: 2019 end-page: 374 ident: bib26 article-title: Sjögren’s syndrome and autoimmune thyroid disease: two sides of the same coin publication-title: Clin. Rev. Allergy Immunol. – volume: 93 start-page: 375 year: 2020 end-page: 389 ident: bib21 article-title: Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: a systematic review and meta-analysis publication-title: Clin. Endocrinol. – volume: 222 start-page: 1439 year: 2020 end-page: 1443 ident: bib4 article-title: Immunoserologic detection and diagnostic relevance of cross-reactive autoantibodies in coronavirus disease 2019 patients publication-title: J. Infect. Dis. – year: 2020 ident: bib13 article-title: Prothrombotic antiphospholipid antibodies in COVID-19 publication-title: MedRxiv – year: 2020 ident: bib18 article-title: Diverse functional autoantibodies in patients with COVID-19 publication-title: MedRxiv Prepr. Serv. Heal. Sci. – volume: 79 year: 2020 ident: bib20 article-title: Antinuclear autoantibodies: discordance among four different assays publication-title: Ann. Rheum. Dis. – volume: 8 start-page: 1233 year: 2020 end-page: 1244 ident: bib29 article-title: Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes publication-title: Lancet Respir. Med. – volume: 83 start-page: 943 year: 2015 end-page: 950 ident: bib19 article-title: Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus publication-title: Clin. Endocrinol. – volume: 57 start-page: 389 year: 2020 end-page: 399 ident: bib30 article-title: Biomarkers associated with COVID-19 disease progression publication-title: Crit. Rev. Clin. Lab Sci. – year: 2013 ident: bib17 publication-title: Autoimmunity: from Bench to Bedside – year: 2020 ident: bib16 article-title: IgM autoantibodies recognizing ACE2 are associated with severe COVID-19 publication-title: MedRxiv – year: 2020 ident: bib14 article-title: Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection publication-title: MedRxiv – volume: 72 start-page: 1953 year: 2020 end-page: 1955 ident: bib3 article-title: Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity publication-title: Arthritis Rheum. – volume: 95 start-page: 304 year: 2020 end-page: 307 ident: bib28 article-title: Mild versus severe COVID-19: laboratory markers publication-title: Int. J. Infect. Dis. – year: 1995 ident: bib22 article-title: Statistique Exploratoire Multidimensionnelle – year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib16 article-title: IgM autoantibodies recognizing ACE2 are associated with severe COVID-19 publication-title: MedRxiv – volume: 222 start-page: 1439 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib4 article-title: Immunoserologic detection and diagnostic relevance of cross-reactive autoantibodies in coronavirus disease 2019 patients publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiaa485 – year: 1995 ident: 10.1016/j.jtauto.2021.100091_bib22 – year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib14 article-title: Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection publication-title: MedRxiv – volume: 83 start-page: 943 year: 2015 ident: 10.1016/j.jtauto.2021.100091_bib19 article-title: Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus publication-title: Clin. Endocrinol. doi: 10.1111/cen.12662 – start-page: 13126 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib12 article-title: High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? publication-title: J. Intern. Med. – volume: 95 start-page: 304 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib28 article-title: Mild versus severe COVID-19: laboratory markers publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2020.04.061 – volume: 79 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib20 article-title: Antinuclear autoantibodies: discordance among four different assays publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2018-214693 – volume: 38 start-page: 754 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib9 article-title: Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases publication-title: Clin. Exp. Rheumatol. – volume: 57 start-page: 389 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib30 article-title: Biomarkers associated with COVID-19 disease progression publication-title: Crit. Rev. Clin. Lab Sci. doi: 10.1080/10408363.2020.1770685 – volume: 13 start-page: 1077 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib2 article-title: Clinical and autoimmune characteristics of severe and critical cases of COVID-19 publication-title: Clin. Transl. Sci. doi: 10.1111/cts.12805 – volume: 98 year: 2019 ident: 10.1016/j.jtauto.2021.100091_bib24 article-title: Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2018.11.002 – start-page: 2020 year: 2021 ident: 10.1016/j.jtauto.2021.100091_bib32 article-title: Autoimmunity to the lung protective phospholipid-binding protein annexin A2 predicts mortality among hospitalized COVID-19 patients publication-title: MedRxiv – year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib13 article-title: Prothrombotic antiphospholipid antibodies in COVID-19 publication-title: MedRxiv – year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib31 article-title: The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities publication-title: Eur. J. Gastroenterol. Hepatol. Publish Ah – volume: 56 start-page: 362 year: 2019 ident: 10.1016/j.jtauto.2021.100091_bib26 article-title: Sjögren’s syndrome and autoimmune thyroid disease: two sides of the same coin publication-title: Clin. Rev. Allergy Immunol. doi: 10.1007/s12016-018-8709-9 – volume: 11 start-page: 2692 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib5 article-title: Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.584241 – volume: 114 start-page: 102506 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib1 article-title: Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2020.102506 – volume: 3 start-page: 100073 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib6 article-title: Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19) publication-title: J. Transl. Autoimmun. doi: 10.1016/j.jtauto.2020.100073 – volume: 72 start-page: 1953 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib3 article-title: Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity publication-title: Arthritis Rheum. doi: 10.1002/art.41409 – volume: 8 start-page: 1233 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib29 article-title: Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(20)30404-5 – volume: 79 start-page: 1661 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib10 article-title: Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2020-218009 – year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib11 article-title: Presence of antiphospholipid antibodies in COVID-19: case series study publication-title: Ann. Rheum. Dis. – year: 2013 ident: 10.1016/j.jtauto.2021.100091_bib17 – volume: 349 start-page: 1526 year: 2003 ident: 10.1016/j.jtauto.2021.100091_bib23 article-title: Development of autoantibodies before the clinical onset of systemic lupus erythematosus publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa021933 – volume: 80– start-page: 370 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib15 article-title: Autoantibodies against type I IFNs in patients with life-threatening COVID-19 publication-title: Science – year: 2021 ident: 10.1016/j.jtauto.2021.100091_bib7 article-title: SARS-CoV-2 infection as a trigger of autoimmune response publication-title: Clin. Transl. Sci. n/a doi: 10.1111/cts.12953 – year: 2021 ident: 10.1016/j.jtauto.2021.100091_bib8 article-title: COVID-19 and immunological dysregulation: can autoantibodies be useful? publication-title: Clin. Transl. Sci. doi: 10.1111/cts.12908 – volume: 93 start-page: 375 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib21 article-title: Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: a systematic review and meta-analysis publication-title: Clin. Endocrinol. doi: 10.1111/cen.14304 – volume: 42 start-page: 76 year: 2019 ident: 10.1016/j.jtauto.2021.100091_bib25 article-title: Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.03.063 – volume: 324 start-page: 1330 year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib27 article-title: Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19 publication-title: J. Am. Med. Assoc. doi: 10.1001/jama.2020.17023 – year: 2020 ident: 10.1016/j.jtauto.2021.100091_bib18 article-title: Diverse functional autoantibodies in patients with COVID-19 publication-title: MedRxiv Prepr. Serv. Heal. Sci. |
| SSID | ssj0002511162 |
| Score | 2.3739944 |
| Snippet | Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2 infection. Herein, we evaluate the presence of rheumatic, thyroid and... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 100091 |
| SubjectTerms | Autoimmunity Clusters COVID-19 Latent autoimmunity Research paper SARS-CoV-2 |
| Title | Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19 |
| URI | https://dx.doi.org/10.1016/j.jtauto.2021.100091 https://www.ncbi.nlm.nih.gov/pubmed/33681751 https://www.proquest.com/docview/2498996907 https://pubmed.ncbi.nlm.nih.gov/PMC7920824 https://doaj.org/article/9008e630892c41a9b31e5d74a919dccc |
| Volume | 4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDcLpTISRyziRx4-0kJVEI8LRT1h-RVtqiq72s0eyq9nxk5Wu3DYC4dcHNuxPWPPZ2f8DSFvnBNNUwXBbPCKKcCszFWuYIDMeWGRDiTRF3_9Vl1cqs9X5dVOqC_0Ccv0wHng3mkwUrGSRaOFV9xqJ3ksQ62s5jp473H1BZu3s5nCNRiBM0_RREXZaKYLXUz35pJz1_VgNwPe_RMc_QQKzffsUqLv3zNP_8LPv70od8zS-QNyf8ST9H3ux0NyJ_aPyN0cYfL2Mfn1BbBkP9DVPG4SOetbCpJZLbpAbR_ocr5Yw3PTLTEB2tql6yLDLe16Oh9DinS_I-TM_Ktrige39Oz7z08fGNdPyOX5xx9nF2wMqcB8KfTA2rYKFsatDkJF6asaJIXMtBb2WV5bYXXjytZKWAKD0ArhVNm0wVVC89ZyJ5-So37Rx-eESgVVaC8tYjLXchdVLavStwBCfOPUjMhpQI0f-cYx7MWNmRzLrk0Wg0ExmCyGGWHbUsvMt3Eg_ynKapsX2bJTAuiQGXXIHNKhGaknSZsReGRAAVV1Bz7_elIMA_MSf7bYPi42awPbWhhZPHuYkWdZUbaNlLJqALZB6XpPhfZ6sf-m7-aJ-7vWAkCbevE_uv2S3MOu5AOlY3I0rDbxFUCswZ2k2XSSzr7-AABUI2s |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Latent+rheumatic%2C+thyroid+and+phospholipid+autoimmunity+in+hospitalized+patients+with+COVID-19&rft.jtitle=Journal+of+translational+autoimmunity+%28Online%29&rft.au=Anaya%2C+Juan-Manuel&rft.au=Monsalve%2C+Diana+M.&rft.au=Rojas%2C+Manuel&rft.au=Rodr%C3%ADguez%2C+Yhojan&rft.date=2021-01-01&rft.pub=Elsevier+B.V&rft.issn=2589-9090&rft.eissn=2589-9090&rft.volume=4&rft_id=info:doi/10.1016%2Fj.jtauto.2021.100091&rft.externalDocID=S2589909021000113 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2589-9090&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2589-9090&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2589-9090&client=summon |